Fig. 4. (A) The effect of PGE2 on cAMP release

Slides:



Advertisements
Similar presentations
Implications novel action of P2RX7 signaling – aids in monocyte’s role of resolving inflammation via the production of angiogenic factors targeting of.
Advertisements

Supplemental Fig. S1. 4T1 Cells Do Not Express Functional  2 -AR. High dose DEX-induced effects on 4T1 (A) proliferation and (B) VEGF production in vitro.
Volume 67, Issue 1, Pages (January 2005)
Fig. 3. IL-4, IFN-γ, and IL-17 production from α-GalCer-stimulated iNKT cells following FlaB treatment of PBMC cultures from asthma patients and healthy.
Fig. 2. Neuroprotective effects of ex-4 through the G protein-coupled GLP-1 receptor. (A) Infarct volume was assessed by TTC staining after tMCAO in rats.
Fig. 2. Comparison of the Th1/Th2 ratio and the percentages of Th1 and Th2 cells between normal and allergic individuals. (A) The Th1/Th2 ratio observed.
Fig. 5. Effects of siRNA against TLR2 and TLR5 on the expression of thymic stromal lymphopoietin (TSLP) from nasal polyp fibroblasts. Fibroblasts were.
Fig. 3. ATME inhibits VEGF-induced invasion and tube formation of endothelial cells. (A) Effect of ATME on HUVEC invasion by using the Transwell culture.
Fig. 2. Effect of PGE2 on VEGF production in NPDFs as determined by RT-PCR (A, C) and ELISA (B, D). (A, B) RT-PCR and ELISA showed that the relative ratio.
Volume 67, Issue 1, Pages (January 2005)
Volume 66, Issue 3, Pages (September 2004)
Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated.
Prostaglandin E2 inhibits mast cell–dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor  Jesper Säfholm,
Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi.
Histamine H2 receptor stimulation upregulates TH2 chemokine CCL17 production in human M2a macrophages  Susanne Mommert, PhD, Karl Gregor, MD, Kristine.
Vascular endothelial dysfunction in cirrhosis
Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action  D.A. Payne, FRCS(Ed)a,
Aikaterini Detoraki, MD, PhD, Rosaria I
Regulation of Human Internal Mammary and Radial Artery Contraction by Extracellular and Intracellular Calcium Channels and Cyclic Adenosine 3′, 5′ Monophosphate 
Volume 137, Issue 3, Pages (September 2009)
Minoxidil-Induced Hair Growth is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target.
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Efren Rael, MD, FAAAAI  Journal of Allergy and Clinical Immunology 
J. -I. Satoh, M. Yamakage, T. Kobayashi, N. Tohse, H. Watanabe, A
The key pathological mechanisms underlying vascular changes in pulmonary hypertension (PH). The key pathological mechanisms underlying vascular changes.
Volume 81, Issue 12, Pages (June 2012)
Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation  Thomas Bärnthaler, MD, Katharina Jandl, PhD, Heinz Sill,
Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro.
Gabriele Di Luozzo, MD, Jaya Bhargava, PhD, Richard J. Powell, MD 
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Estrogens and androgens affect human luteal cell function
Prostaglandin E2 suppresses staphylococcal enterotoxin–induced eosinophilia- associated cellular responses dominantly through an E-prostanoid 2–mediated.
Cyclooxygenase-2 in the kidney: good, BAD, or both?
Implication of prostaglandin E2 in TNF-α-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs  K. Fushimi,
The use of defibrotide in blood and marrow transplantation
Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease  Tanya M. Laidlaw, MD, Anya J. Cutler, Molly S.
Simona Nemcova, MD, Peter Gloviczki, MD, Kevin S. Rud, Virginia M
Dopamine Receptor Activation By Honey Bee Queen Pheromone
Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules  Josiane S. Neves,
Decreased Prostaglandin E2 Production by Inflammatory Cytokine and Lower Expression of EP2 Receptor Result in Increased Collagen Synthesis in Keloid.
Jun Asai, Hideya Takenaka, Norito Katoh, Saburo Kishimoto 
Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal- stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor 
Comparison of the serum levels of the three vascular endothelial growth factor (VEGF) types in healthy volunteers and patients with idiopathic pulmonary.
Vascular endothelial growth factor in patients with acute asthma
Specific signal transduction mechanisms
Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell–dependent manner through cysteinyl leukotriene.
Fig. 3. (A) Effect of EP receptor agonists on VEGF production by NPDFs
Expression and function of histamine receptors in human monocyte-derived dendritic cells  Marco Idzko, MDa, Andrea la Sala, PhDb, Davide Ferrari, PhDc,
Fig. 7. Effect of capsazepine and TRPV1 siRNA on total collagen levels
Fig. 5. (A) The effect of PKA and PI3K inhibitors on VEGF production in NPDFs. KT5720 and LY significantly decreased VEGF production. (B) The effect.
Fig. 6. Mucus analysis of lungs from allergic and tolerized mice
Fig. 2. GCE induces allergic inflammation in the mouse model of asthma
Mechanism of action for pulmonary arterial hypertension medications.
Fig. 2. Binding of specific IgE to D20110 and S47W
Volume 56, Issue 2, Pages (August 1999)
Clinical and pathologic perspectives on aspirin sensitivity and asthma
Fig. 1. Treatment with IL-13 induces proliferation and migration of BSMCs. (A) MTT assay was performed to evaluate the effects of IL-13 on the proliferation.
*P < 0.01; †P < The experiments were repeated 5 times.
*P < 0.01; †P < The experiments were repeated 5 times.
*P < 0.01 and †P < The experiments were repeated 6 times.
Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking  Viktoria Konya, PhD, Andreas Üllen, PhD, Nora Kampitsch,
Supplementary Fig. S1. A summary of the suggested mechanism underlying asthma. PAR2, activated by a protease-containing allergen, induces the generation.
*P < 0.05; †P < The experiments were repeated 5 times.
*P < The experiments were repeated 5 times.
Fig. 4. The expression of TRAF6 in the PBMCs of the AR children after a 3-month SIT treatment. (A) Representative Western blot analysis of TRAF6 in the.
Fig. 4. The inhibition of mast cell infiltration by topical application of the TECA + AST combination in dorsal ear and back skin. Mast cell infiltrations.
Fig. 1. Differences in body weight, dorsal ear skin thickness and phenotypes, as well as back skin phenotypes. Body weights of mice in the 5 groups were.
Fig. 1. Relationship between obesity and atopic dermatitis
Fig. 1. Immunohistochemical staining for TMEM16A and MUC5AC in human sinonasal epithelium: TMEM16A and MUC5AC proteins in human nasal polyp epithelium.
Fig. 5. Can f 4-specific mAbs and the sandwich ELISA for the quantification of Can f 4. (A) The epitope specificity of the three Can f 4-specific mAbs.
Presentation transcript:

Fig. 4. (A) The effect of PGE2 on cAMP release Fig. 4. (A) The effect of PGE2 on cAMP release. PGE2 stimulated cAMP release in a dose-dependent manner. (B) The effect of forskolin on VEGF production. Forskolin increased VEGF production in a dose-dependent manner. *P<0.05 and †P<0.01 vs. the control. (C) The effect of cAMP on VEGF production via the EP4 receptor. CAY10580 increased cAMP release. When AH 23848 was added before the treatment of PGE2, cAMP level was significantly decreased. The means±SE of data from six experiments are shown. *P<0.05 vs. control and †P<0.05 vs. PGE2. cAMP, cyclic adenosine monophosphate; PGE2, prostaglandin E2; VEGF, vascular endothelial growth factor; EP, E-prostanoid; CAY10580, EP4 receptor agonist; AH23848, EP4 receptor antagonist; Forskolin, cAMP activator; SE, standard error. Fig. 4. (A) The effect of PGE2 on cAMP release. PGE2 stimulated cAMP release in a dose-dependent manner. (B) The effect of forskolin on VEGF production. Forskolin increased VEGF production in a dose-dependent manner. *P<0.05 and †P<0.01 vs. the control. (C) The effect of cAMP on VEGF production via the EP4 receptor. CAY10580 increased cAMP release. When AH . . . Allergy Asthma Immunol Res. 2013 Jul;5(4):224-231. http://dx.doi.org/10.4168/aair.2013.5.4.224